To Top

Community

Nigel Walker

Mr. Walker is the founder and managing director of That’s Nice LLC, a research-driven marketing agency with 20 years dedicated to life sciences. Nigel harnesses the strategic capabilities of Nice Insight, the research arm of That’s Nice, to help companies communicate science-based visions to grow their businesses. Mr. Walker earned a bachelor’s degree in graphic design with honors from London College.

Contribution
Breakthrough Therapy

Xolair Gets Breakthrough Therapy Designation from US FDA for Treatment of Food Allergies

PAO-M08-18-NI-016
Quality Metrics

FDA Makes More Quality Moves

PAO-M08-18-NI-006
Research

New Understanding of Muscle-Repair Cells May Lead to Treatments for Neurological Diseases

PAO-M08-18-NI-004
Funding

IFM Gets Funding to Support Work on NLRP3 Inhibitors

PAO-M07-18-NI-016
FDA Approval

Xtandi Gets FDA Second Cancer Therapy Approval

PAO-M07-18-NI-012
FDA

FDA Committee Gives Nod to New Treatment for Plasmodium Vivax Malaria

PAO-M07-18-NI-010
FDA Approval

New Treatment for Excessive Sweating Gets FDA Approval

PAO-M07-18-NI-008
Clinical Research

Eating Well Might Improve Cancer Treatments

PAO-M07-18-NI-006
Innovation

Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease

PAO-M06-18-NI-005
Strategic Partnership

Partnerships Between Bayer and DoE Formed to Produce Radioactive Pharma Intermediate

PAO-M06-18-NI-003
R&D

Researchers Find Link between Tuberculosis and Parkinson’s Disease

PAO-M05-18-NI-025
Next-Generation Biopharma

Changes in the Biopharma Industry: from Minor to Major Evolution

PAP-Q2-18-NI-002
Immunotherapy

Cancer Immunotherapies Reach Patients More Quickly Than Other Drugs

PAO-M05-18-NI-013
Diagnostics

Development of Blood Tests for Early Cancer Detection May Be Possible

PAO-M04-18-NI-020
Antibiotics

Macrolide Attracts Funding and Executive Talent

PAO-M04-18-NI-004
Radio-Conjugates

Companies Join Forces to Develop Novel Radio-Conjugates

PAO-M04-18-NI-002
Clinical Data

Clinical Study Data for New MS Drug Looks Promising

PR-M03-18-NI-101
Acquisition

Citoxlab Acquires Solvo Biotechnology    

PAO-M03-18-NI-025
Anti-Aging

Additional Funding for Unity’s First Human Clinical Study

PAO-M03-18-NI-016
Oncology

MSD Launches Herceptin Biosimilar in UK

PAO-M03-18-NI-015
M&A Activity

M&A Activity in a Fragmented CDMO Market

PAP-Q1-18-NI-001
Influenza

New BI Vaccine Allows Very Early Vaccination of Piglets Against Swine Flu

PAO-M03-18-NI-010
Results

Lilly Reports Results of Migraine Survey

PAO-M03-18-NI-007
Digital

Novartis in Collaboration to Develop Software Applications

PAO-M03-18-NI-006
Drug Development

HEPAXA is a New Treatment in the US from BASF for Patients with NAFLD

PAO-M02-18-NI-023
Drug Development

Kidney Disease Drug Licensed to AstraZeneca

PAO-M02-18-NI-022
Oncology

Device Plus Drug Approved for Bladder Cancer Detection

PAO-M02-18-NI-018
Investment

China Invests Heavily in Western Biotech

PAO-M02-18-NI-013
Clinical Trials

Tyzivumab is Ready for Trials

PAO-M02-18-NI-011
Acquistion

Celanese Completes Omni Acquisition

PAO-M02-18-NI-009
Investment

Dracen Pharmaceuticals Raises Over $40 million

PAO-M02-18-NI-007
Animal Nutrition

Versamaris JV Formed by DSM and Evonik

PAO-M02-18-NI-004
Oncology

Stopping Cancer Cell Division Using Targeted Enzyme Control

PAO-M02-18-NI-001
Vaccine

EMA Committee Gives Positive Recommendation to GSK’s Shingles Vaccine

PAO-M01-18-NI-046
Cell and Gene Therapy

Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities

PAO-M01-18-NI-042
Clinical Trial

Amgen and Novartis Reach an Important Milestone

PAO-M01-18-NI-041
Investment

Contract Research Organization Growth and Investment

APR-M10-17-NI-001
FDA Approval

FDA to Expand the Use of Gilotrif

PAO-M01-18-NI-038
Acquisition

Charles River Laboratories Continues to Grow Through Acquisition

PAO-M01-18-NI-035
Biologics

EU Approves AstraZeneca’s Respiratory Biologic

PAO-M01-18-NI-031
Digital Platform

Clinical Decision-support Software to be Developed by Roche and GE Healthcare

PAO-M01-18-NI-028
Immunology

Charles River Laboratories Gains Immunology Contract Research Services

PAO-M01-18-NI-023
Development Agreement

Arvinas Protein Degradation Technology Attracts Pfizer’s Attention

PAO-M01-18-NI-020
Licensing Agreement

Generex Biotech and Shenzhen BioScien Enter into Licensing Agreement

PAO-M01-18-NI-014
Biologics

New Class of Exosome Biologics Focuses on Stroke Treatment

PAO-M01-18-NI-011
Cell and Gene Therapy

FDA Approves Gene Therapy

PAO-M01-18-NI-005
Drug Delivery

Building DNA and RNA Origami for Drug Delivery

PAO-M01-18-NI-003
Chemistry

Hot Electrons Might Enable New Synthetic Methods

PAO-M12-17-NI-039
Oncology

Altering White Blood Cells to Kill Cancer

PAO-M12-17-NI-026
FDA

New FDA Draft Guidance Intended to Accelerate Development of Drugs for Rare Pediatric Diseases

PAO-M12-17-NI-023
Diagnostics

Emerging Lyme Disease Tests Found Efficacious

PAO-M12-17-NI-014
Medical Application

FDA Clears KardiaBand Apple Watch Heart Monitoring App

PAO-M12-17-NI-006
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

PAO-M12-17-NI-008
Strategic Partnership

New Collaboration Targets the Development of Oligonucleotides

PAO-M12-17-NI-002
Adherence

Digital Technology Makes It into Medicines

PAO-M11-17-NI-044
BioRobotics

Bioengineered Robotic Hand Senses Touch

PAO-M11-17-NI-039
Antibiotics

Simplified Versions of Teixobactin Could Be Commercialized

PAO-M11-17-NI-034
Oncology

Intrauterine Devices Offer New Benefit

PAO-M11-17-NI-030
Drug Discovery

Novel Compound Developed That Could Serve as a Non-Addictive Opiod Alternative

PAO-M11-17-NI-027
Business

Grand River Aseptic Manufacturing Announces Majority Investment by Arlington Capital Partners

PR-M11-17-NI-014
Strategic Partnership

QuintilesIMS Now IQVIA

PAO-M11-17-NI-024
Diagnostics

Ultrasound Transducer from Butterfly Network Receives FDA Approval for 13 Applications

PAO-M11-17-NI-023
FDA

EMA, FDA Move Forward with Mutual Recognition of Inspections

PAO-M11-17-NI-017
Drug Development

NIH Funds Bacterial DNA Superbug Killer

PAO-M11-17-NI-014
Pregnancy Tracker

Ovarian Cycle Bracelet Detects Pregnancy in Trials

PAO-M11-17-NI-010
Oncology

Intelligent Nanoparticles Kill Cancer Cells

PAO-M11-17-NI-005
FDA

FDA, European Regulators Align for More Efficient GMP Inspections

PAO-M11-17-NI-002
Nice Insight Overview

From Digitalization to Nanoscale Delivery: Emerging Technologies Are Driving the Future of Pharma

PAP-Q4-17-NO-001
Genetics

Unlocking the Relationship Between Genetics and Disease

PAO-M10-17-NI-044
Medical Application

Smart Phone Compatible Cardiac Monitor Launched

PAO-M10-17-NI-038
Oncology

Study Finds Beta Blockers Interrupt Nerves Sustaining Prostate Tumor Growth

PAO-M10-17-NI-036
Innovation

Lab-on-a-chip Technology Advancing Treatments for Lung Cancer

PAO-M10-17-NI-029
Clinical Trials

Alzheimer’s Clinical Trial Focused on Restoring Lost Brain Connections

PAO-M10-17-NI-028
FDA

FDA Holds First Patient Engagement Advisory Committee Meeting

PAO-M10-17-NI-023
3D Printing

New 3D Printing Lab Dedicated to Pharma Opens in Sweden

PAO-M10-17-NI-020
Cell and Gene Therapy

Gene Therapy Stabilizes Neurodegenerative Disease

PAO-M10-17-NI-013
FDA

FDA Finalizes Emerging Drug Manufacturing Technology Guidance

PAO-M10-17-NI-012
FDA Approval

Eli Lilly Gets Early Approval for Breast Cancer Drug

PAO-M10-17-NI-006
Discovery

NIH Funds Novel Small Molecule Approach to Interrupt Alzheimer’s Dementia

PAO-M10-17-NI-003
Innovation

Modeling Mechanisms for Crossing the Blood-Brain Barrier

PAO-M09-17-NI-033
Innovation

Alliance Aims to Develop Novel Mass Spectrometry Sample Handling Technology

PAO-M09-17-NI-031
Innovation

New Organ-On-A-Chip Designed to Model Influenza Virus Infections

PAO-M09-17-NI-025
Big Data

Big Data Alliance Aims to Advance Cancer Treatments

PAO-M09-17-NI-021
ADC

Pfizer Gets Second ADC Approval in 2017

PAO-M09-17-NI-019
Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

PAP-Q3-17-NO-001
Design Logic

Marken: Stronger Than Ever

PAP-Q3-17-DL-001
Drug Delivery

Perfusion Appears to be Gaining Traction in Biopharma Manufacturing

POP-M08-17-NI-001
Non-adherence

Analysis Confirms Majority of Americans are Misusing Their Prescriptions

PAO-M09-17-NI-014
FDA

Collaborations within FDA Intended to Improve Facility Inspections and Facilitate Drug Approvals

PAO-M09-17-NI-010
Partnership

Magnetic Bead Technology Activates Novartis’ CAR-T Therapy

PAO-M09-17-NI-007
Clinical Data

Multiple Sclerosis Study First to Collect Data from Patient Smartphones

PAO-M08-17-NI-038
Drug Development

Tuberculosis Drugs Under Development in New Collaboration

PAO-M08-17-NI-032
Zika Virus

Researchers Equipped with New Zika Virus Diagnostic Development Tool

PAO-M08-17-NI-030
Innovation

An Existing Diabetes Drug Could Help Patients with Parkinson’s Disease

PAO-M08-17-NI-025
Oncology

Genetic Analysis of Solid Tumors Provides Insight on How They Spread

PAO-M08-17-NI-020
Innovation

Celgene’s First-Ever Oral Leukemia Treatment Gets FDA Nod

PAO-M08-17-NI-012
Capacity Expansion

Boehringer Ingelheim Expands Biologics Manufacturing Capacity in California

PAO-M08-17-NI-007
Partnership

Merck and AstraZeneca Team Up to Fight Cancer

PAO-M08-17-NI-001
FDA

Vosevi Hepatitis C Treatment Approved by the FDA

PAO-M07-17-NI-028
FDA

Johnson & Johnson Gets FDA Nod for New Treatment for Plaque Psoriasis

PAO-M07-17-NI-023
Innovation

Regenerating Knee Cartilage with Stem Cells

PAO-M07-17-NI-020
Cell and Gene Therapy

Shire Submits IND for Hemophilia A Gene Therapy

PAO-M07-17-NI-016
FDA

Unjamming the Orphan Drug Backlog

PAO-M07-17-NI-009
Continuous Manufacturing

EMA Approves Continuous Manufacture of Prezista

PAO-M07-17-NI-002
Innovation

FDA Approves Two Drugs for the Treatment of ADHD

PAO-M06-17-NI-021
Drug Delivery

Recombinant Flu Vaccine Outperforms Egg-based Alternatives

PAO-M06-17-NI-019
Innovation

The New Wave In Cancer Screening: Liquid Biopsy Testing

APR-M04-17-NI-001
FDA

FDA Fast Track Designation Granted for Pfizer and Eli Lilly’s Innovative Pain Treatment

PAO-M06-17-NI-010
Excipient

Trends In Excipient Demand

PMP-M06-17-NI-001
Innovation

US Diabetes Patients Now Have Access to an “Artificial Pancreas” for Automatic Insulin Delivery

PAO-M06-17-NI-012
Innovation

New Data May Lead to the Development of Drugs to Prevent Heart Problems in Diabetics

PAO-M06-17-NI-004
Biologics

The Road to Biologics’ Continued Success

PAP-Q2-17-EN-001
Biologics

Biologics: Driving Force in Pharma

PAP-Q2-17-NO-001
CRISPR

MilliporeSigma Increases the Efficiency of Gene Editing

PAO-M05-17-NI-030
Blockbuster

Johnson & Johnson Looks Forward to Ten Blockbuster Drugs by 2021

PAO-M05-17-NI-023
Drug Delivery

Trends in the Topical Delivery of Dermatology Medications

MCM-M05-NI-001
Innovation

Pfizer Collaborates with Gene Editing Company Sangamo Therapeutics on Hemophilia A Treatment

PAO-M05-17-NI-022
Clinical Trials

Harmonized Protocol Templates Available for Clinical Trial Sponsors

PAO-M05-17-NI-013
Acquisition

Fresenius Kabi Expands its Generics and Biosimilars Businesses

PAO-M05-17-NI-006
Immuno-oncology Therapies

Combinational Immunotherapies: The Bright Future of Cancer Treatment

MCP-M04-17-NI-001
CDMO

Latest Developments in Cellular and Gene Therapies

MCP-M03-17-NI-001
FDA

Novartis CAR-T Cell Therapy Receives Breakthrough Therapy Designation

PAO-M04-17-NI-025
API

Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization

POP-M03-17-NI-001
Discovery

Fusion Antibodies, MAB Discovery Team to Speed Antibody Development

PAO-M04-17-NI-018
Discovery

23andMe Personal Genome Service Gets FDA Nod

PAO-M04-17-NI-015
Biologics

GermFree Bio Introduces Mobile GMP Cleanroom Platform

PAO-M04-17-NI-009
Clinical Trials

Verona Turns to QuintilesIMS for Drug Development

PAO-M03-17-NI-004
CDMO

Cracking Soil’s Microbiome: Biopesticides and Plant Biostimulants

SCP-M03-17-NI-001
CDMO

Pfizer CentreOne Expands on Two Fronts

PAO-M03-17-NI-015
CDMO

Fine Industries Sold to Lianhetech

PAO-M03-17-NI-009
Discovery

Big Data: A Big Challenge

PAP-Q1-17-NO-001
CDMO

Keys to Cultural Integration

PAP-Q1-17-QA-001
CDMO

Nice Symposium Oral Solid Dose Thank You to Our 2017 Sponsors

PAP-Q1-17-NS-001
Discovery

Move Toward Cell-Based Manufacturing Signals Opening in Vaccine Market

MCP-M02-17-NI-002
Equipment

Supplier Integrity and Polymer Performance Remain Important for Innovating Single-Use Manufacturing

POP-M02-17-NI-001